As shown in Fig. 1c and d, myofibroblasts in the dermis of American patients with early dcSSc (< 3 years from first non-Raynaud manifestation) displayed a significantly increased PTP4A1/PTP4A2 signal when compared to those from late dcSSc (> 3 years from first non-Raynaud manifestation), limited SSc and normal controls. The gene discussed is PTP4A2; the disease is systemic sclerosis.